Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomised, Parallel-Group Comparison of Ethyl-Eicosapentaenoic Acid (Ethyl-EPA) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia

NCT00114595 is registered in ClinicalTrials.gov with University of Stellenbosch as lead sponsor.

NCT NCT00114595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00114595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomised, Parallel-Group Comparison of Ethyl-Eicosapentaenoic Acid (Ethyl-EPA) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia
Lead sponsor
University of Stellenbosch
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2005
Enrollment
84
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesia, schizophrenia